Leukemia Research

Papers
(The H4-Index of Leukemia Research is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The specificity of asciminib, a potential treatment for chronic myeloid leukemia, as a myristate-pocket binding ABL inhibitor and analysis of its interactions with mutant forms of BCR-ABL1 kinase79
A concise review on the molecular genetics of acute myeloid leukemia42
Murine double minute 2 inhibition alone or with cytarabine in acute myeloid leukemia: Results from an idasanutlin phase 1/1b study⋆36
Impact of long-term ibrutinib treatment on circulating immune cells in previously untreated chronic lymphocytic leukemia29
A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival22
Venetoclax and hypomethylating agent combination therapy in acute myeloid leukemia secondary to a myeloproliferative neoplasm21
Plasma cell leukemia: A review of the molecular classification, diagnosis, and evidenced-based treatment21
Exosome-derived miR-let-7c promotes angiogenesis in multiple myeloma by polarizing M2 macrophages in the bone marrow microenvironment20
Isatuximab plus pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma according to prior lines of treatment and refractory status: ICARIA-MM subgroup analysis20
Clonal hematopoiesis: Molecular and clinical implications20
Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemia19
Thrombotic events and mortality risk in patients with newly diagnosed polycythemia vera or essential thrombocythemia19
Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells19
Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience17
Long non-coding RNA CRNDE suppressing cell proliferation is regulated by DNA methylation in chronic lymphocytic leukemia17
Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement16
Efficacy and safety following bosutinib dose reduction in patients with Philadelphia chromosome‒positive leukemias16
0.10702681541443